Biomarkers for Diabetes

Biomarker”, are called “molecular marker” or a “signature molecule”. These viewed as direct or indirect markers of the extent of disease as they lay outside in a casual way. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored. Cases over the past two decades have yielded sample sets, mostly blood products and urine from a large category of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland
February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
April 29-30, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 10-11, 2019

28th European Diabetes Congress

|| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in